《大行報告》高盛升小米(01810.HK)目標價至33元 首季純利增長快於預期
高盛發表報告指,小米集團(01810.HK)今年首季淨利潤按年升164%快過預期,並優於該行及市場原預期各29%及35%,公司首季收入按年升55%至769億元人民幣(下同)亦快過預期,期內先利率18.4%,較去年第四季擴闊2個百分點,主要受惠智能手機利潤改善及高端化等。
該行表示,維持對小米集團收入預測大致不變,但就將小米2021至2023年按非國際財務報告準則經調整淨利潤淨利潤預測各上調15%、8%及4%,以反映智能手機高端化帶動毛利率上升,同時高毛利的互聯網服務收入貢獻亦有所增加,不過相關因素部分被新能源車研發投資所抵銷。
高盛稱,上調對小米目標價由30元升至33元,意味有17%的上行空間,維持「買入」評級。(el/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.